ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

CUSIP: 29251M106

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
28,862,345
Total 13F shares
14,626,888
Share change
-509,571
Total reported value
$483,060,372
Put/Call ratio
812%
Price per share
$33.02
Number of holders
132
Value change
-$20,743,890
Number of buys
67
Number of sells
67

Quarterly Holders Quick Answers

What is CUSIP 29251M106?
CUSIP 29251M106 identifies ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2015

As of 31 Dec 2015, ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by 132 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,626,888 shares. The largest 10 holders included Apex Capital Management, BlackRock Fund Advisors, EAGLE ASSET MANAGEMENT INC, Krensavage Asset Management, LLC, ACADIAN ASSET MANAGEMENT LLC, FMR LLC, Invesco Ltd., VANGUARD GROUP INC, STATE STREET CORP, and ORBIMED ADVISORS LLC. This page lists 132 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.